Testing an IV stem cell treatment for aging frailty safety
Treatments studied
This early study (Phase 1) tests whether a lab-made stem cell product given through an IV is safe in people with “aging frailty.” It looks mainly at side effects and safety while also exploring whether the treatment can be given safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with aging frailty.
- You can understand the study and agree to sign informed consent.
- You do not have an active infection before starting.
- You do not have active cancer or a serious ongoing organ failure affecting multiple organs.
- You are able to meet key safety checks (labs) and your doctor does not think another condition would put you at risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational treatment made from special cells (called mesenchymal stromal cells) that might help reduce frailty in older adults. The treatment is given through an IV and aims to improve strength and overall function.
This study tests a new stem cell medicine given through an IV to see if it is safe for older adults with mild to moderate frailty. Frailty causes weakness and tiredness, and this treatment aims to improve overall health and function.
This Phase 1 study tests whether an IV infusion of stem cells from donated umbilical cord tissue is safe for people with idiopathic pulmonary fibrosis. It focuses mainly on safety and tolerability, and it may help by offering a new treatment approach if the cells are safe for you.
This early study (Phase 1) tests whether an intravenously given, donated stem cell product is safe for people with chronic kidney disease. It mainly looks at side effects and whether the treatment can be given without harming you.
This trial tests whether an IV infusion of lab-made donor stem cells is safe for people with autism. It mainly looks at side effects and whether the treatment can be given without causing harm.
This Phase 1 trial tests how safe an intravenous (through a vein) stem cell product is for people with rheumatoid arthritis. It is mainly looking for side effects and safety rather than proving it works yet.
Hear when a new Frailty trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.